Screening for breast cancer : Time, travel, and out-of-pocket expenses.
We estimated the personal costs to women found to have a breast problem (either breast cancer or benign breast disease) in terms of time spent, miles traveled, and cash payments made for detection, diagnosis, initial treatment, and follow-up.
We analyzed data from personal interviews with 465 women from four communities in Florida.
These women were randomly selected from those with a recent breast biopsy (within 6-8 months) that indicated either breast cancer (208 women) or benign breast disease (257 women).
One community was the site of a multifaceted intervention to promote breast screening, and the other three communities were comparison sites for evaluation of that intervention.
All P values are two-sided.
In comparison with time spent and travel distance for women with benign breast disease (13 hours away from home and 56 miles traveled), time spent and travel distance were statistically significantly higher (P<. 001) for treatment and follow-up of women with breast cancer (89 hours and 369 miles).
Personal financial costs for treatment of women with breast cancer were also statistically significantly higher (breast cancer=$604 ; benign breast disease=$76 ; P<. 001) but were statistically significantly lower for detection and diagnosis (breast cancer=$170 ; benign breast disease=$310 ; P<. 001). (...)
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Homme, Femelle, Dépistage, Canada, Amérique du Nord, Amérique, Analyse coût, Dépense, Revenu individuel, Niveau étude, Temps, Voyage, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Human, Female, Medical screening, Canada, North America, America, Cost analysis, Expenditure, Personal income, Education level, Time, Travel, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0316724
Code Inist : 002B20E02. Création : 16/11/1999.